| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/01/2000 | EP0981728A2 Radiolabeled farnesyl-protein transferase inhibitors |
| 03/01/2000 | EP0981648A1 ANTISENSE INHIBITION OF ras GENE WITH CHIMERIC AND ALTERNATING OLIGONUCLEOTIDES |
| 03/01/2000 | EP0981646A1 Enzymatic dna molecules |
| 03/01/2000 | EP0981610A2 Compositions for treatment of disorders involving programmed cell death |
| 03/01/2000 | EP0981550A1 Methods for eosinophil depletion and compositions therefor |
| 03/01/2000 | EP0981549A1 A method for the improvement of neuronal regeneration |
| 03/01/2000 | EP0981538A1 Pharmaceutically acceptable salts of 5alpha-pregnan-3beta, 16alp ha-diol-20-one 3-sulfate useful as progestins and cns disorders |
| 03/01/2000 | EP0981534A2 Dinucleotides and their uses |
| 03/01/2000 | EP0981532A1 Acyclovir diester derivatives |
| 03/01/2000 | EP0981529A1 A new process for the preparation of a pharmacologically active substance |
| 03/01/2000 | EP0981527A1 Salt of naphthyridine carboxylic acid derivative |
| 03/01/2000 | EP0981526A1 Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| 03/01/2000 | EP0981523A1 CYCLIC ETHER VITAMIN D3 COMPOUNDS, 1$g(a) (OH) 3-EPI-VITAMIN D3 COMPOUNDS AND USES THEREOF |
| 03/01/2000 | EP0981521A2 Novel macrocyclic compounds as metalloprotease inhibitors |
| 03/01/2000 | EP0981520A1 Efficient enantioselective addition reaction using an organozinc reagent |
| 03/01/2000 | EP0981519A1 Methods of modulating serine/threonine protein kinase function with quinazoline-based compounds |
| 03/01/2000 | EP0981517A1 Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents |
| 03/01/2000 | EP0981516A1 Substituted tetrahydroisoquinoline derivatives as modulators of dopamine d?3 receptors |
| 03/01/2000 | EP0981515A1 Piperidine derivatives as neurotransmitter re-uptake inhibitors |
| 03/01/2000 | EP0981514A1 3-epi vitamin d2 compounds and uses thereof |
| 03/01/2000 | EP0981376A1 Targeted therapeutic delivery of vitamin d compounds |
| 03/01/2000 | EP0981375A1 Pharmaceutical compositions containing plasma protein |
| 03/01/2000 | EP0981372A2 Compositions of antichlamydial agents for the diagnosis and management of infection caused by chlamydia |
| 03/01/2000 | EP0981364A1 Method and compositions for treating hyperlipidemia and other conditions |
| 03/01/2000 | EP0981360A1 Method for preventing gastritis using amylin or amylin agonists |
| 03/01/2000 | EP0981358A1 Dolastatin-15 derivatives in combination with taxanes |
| 03/01/2000 | EP0981355A1 Treatment of chronic inflammatory diseases with cm101/gbs toxin |
| 03/01/2000 | EP0981354A1 Condensation polymer composition for preventing pregnancy |
| 03/01/2000 | EP0981353A1 Facilitation of repair of neural injury with cm101/gbs toxin |
| 03/01/2000 | EP0981352A1 Aplidine as an l-type calcium channel enhancer |
| 03/01/2000 | EP0981351A1 Use of diphosphonic acids or the physiologically acceptable salts or esters thereof in the preventive treatment of after-effects resulting from enlargement or replacement of the bladder |
| 03/01/2000 | EP0981350A1 Use of 9,10-secocholesta-5,7,10(19)-triene-1,3-diol, or alfacacidol |
| 03/01/2000 | EP0981349A1 Pregnan-3-ol-20-ones |
| 03/01/2000 | EP0981348A1 The use of levobupivacaine in paediatric surgery |
| 03/01/2000 | EP0981347A1 The use of levobupivacaine in facial surgery |
| 03/01/2000 | EP0981346A1 Use of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)-ethoxy)benzyl)2,4-thiazolidinedione in the treatment of polycystic ovary syndrome and gestational diabetes |
| 03/01/2000 | EP0981345A1 Methods and compositions for the protection of mitochondria |
| 03/01/2000 | EP0981344A1 Inhibition of cell surface protein disulfide isomerase |
| 03/01/2000 | EP0981343A2 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 03/01/2000 | EP0981342A2 Method and composition for treating cancers |
| 03/01/2000 | EP0981341A1 Use of betulinic acid derivatives for the treatment and prevention of melanoma |
| 03/01/2000 | EP0981340A1 Pharmaceutical formulations in dry form for the oral administration of a cyclic quaternary ammonium compound |
| 03/01/2000 | EP0981339A1 Use of a pharmaceutical composition for treating and/or preventing ischemia |
| 03/01/2000 | EP0981338A1 ORAL PREPARATION FOR THE PROPHYLACTIC AND THERAPEUTIC TREATMENT OF $i(HELICOBACTER SP.) INFECTION |
| 03/01/2000 | EP0981337A2 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones |
| 03/01/2000 | EP0981336A2 Use of peroxygen compounds in the control of hairy wart disease |
| 03/01/2000 | EP0981335A1 An enteric coated oral dosage form comprising sodium amoxycillin |
| 03/01/2000 | EP0981334A1 Swallow tablet comprising paracetamol |
| 03/01/2000 | EP0981332A1 Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation |
| 03/01/2000 | EP0981330A1 Topical compositions |
| 03/01/2000 | EP0981328A1 Emulsion vehicle for poorly soluble drugs |
| 03/01/2000 | EP0981327A2 Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors |
| 03/01/2000 | EP0981276A1 6-halo-or nitrate-substituted paclitaxels |
| 03/01/2000 | EP0885060A4 Solid and semi-solid hydrocarbon gels and uses thereof |
| 03/01/2000 | EP0861070B1 Use of nadph oxidase inhibitors for the manufacture of a medicament for prevention of atherosclerosis |
| 03/01/2000 | EP0857063A4 Compositions and methods for buccal delivery of pharmaceutical agents |
| 03/01/2000 | EP0804445B1 Metallocenic diarylethylene derivatives, methods for their preparation and pharmaceutical compositions containing same |
| 03/01/2000 | EP0782573B1 Brefeldin a and analogs to improved synaptic transmission |
| 03/01/2000 | EP0673374B1 Pharmaceutical composition containing bicyclic type compounds |
| 03/01/2000 | EP0641341B1 METHOD FOR PREPARING BENZO [b]NAPHTHYRIDINES |
| 03/01/2000 | EP0594739B1 Cancer treatment |
| 03/01/2000 | EP0513387B1 Thiazole derivatives as active oxygen inhibitors |
| 03/01/2000 | CN1246124A 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 03/01/2000 | CN1246123A Novel erythromycin derivatives, method of preparation and application as medicines |
| 03/01/2000 | CN1246121A Immunosuppressive compounds and methods |
| 03/01/2000 | CN1246120A Imidazopyridazines compound |
| 03/01/2000 | CN1246119A Pyrrolo [3,4-d] pyrimidinone derivatives and their use as medicaments |
| 03/01/2000 | CN1246117A 1,2-dihydroindene or indoline derivatives |
| 03/01/2000 | CN1246116A Sulphonamide derivatives, process for their preparation and their use as medicaments |
| 03/01/2000 | CN1246113A Process for crystallization of reverse transcriptase inhibitor using anti-solvent |
| 03/01/2000 | CN1246111A Novel compound with analgesic effect |
| 03/01/2000 | CN1246110A Arylpiperidinopropanol and arylpiperaznipropanol derivatives and pharmaceuticals containing the same |
| 03/01/2000 | CN1246109A 5-aroylnaphthalene derivatives |
| 03/01/2000 | CN1246057A Oral cyclosporin formulations |
| 03/01/2000 | CN1246054A Use of green porphyrins for manufacture of medicament for treatment of secondary cataracts |
| 03/01/2000 | CN1246041A Spine distraction implant and method |
| 03/01/2000 | CN1246032A Cyanoacrylate compositions comprising antimicrobial agent |
| 03/01/2000 | CN1245810A Preparation of sterol and dihydro-sterol ester |
| 03/01/2000 | CN1245808A Compound resisting hepatitis virus and its preparation method and its application in pharmaceutical technology |
| 03/01/2000 | CN1245803A Method for preparing substituted pyridines |
| 03/01/2000 | CN1245799A Preparation method of pyrrolidyl hydroxamic acid compound |
| 03/01/2000 | CN1245798A New hydroxamic acid compounds, their preparation method and medicine composition containing them |
| 03/01/2000 | CN1245795A Improved method for synthesizing halogenated methylenimine compound |
| 03/01/2000 | CN1245715A Yankang powder (paste) for relieving inflammation |
| 03/01/2000 | CN1245706A Face-nourishing oral liquor and its preparation method |
| 03/01/2000 | CN1245688A Oral nutrient lead-expelling powdered granules |
| 03/01/2000 | CN1245687A Double regulation nutrient health-care product and its preparation method |
| 03/01/2000 | CN1245686A Compound Niuduning oral liquor and its preparation method |
| 03/01/2000 | CN1245685A Bone-strengthening granules |
| 03/01/2000 | CN1245684A Albendazole suspensoid emulsion its preparation method |
| 03/01/2000 | CN1245683A Formula for curing bromhidrosis and yellow sweat |
| 03/01/2000 | CN1049893C Valaciclovic hydrochloride and its preparing method, and its use |
| 03/01/2000 | CN1049891C Dicyclomine compound and preparing method, and drug composition containing said compound |
| 03/01/2000 | CN1049888C Process for preparing benzoylguanidine |
| 03/01/2000 | CN1049831C Plaster for curing hyperosteogeny |
| 03/01/2000 | CN1049821C Medicine for curing tooth ache |
| 03/01/2000 | CN1049820C Etoposide preparations |
| 03/01/2000 | CN1049819C Hyperthyroidism injection and its prepn. method |
| 03/01/2000 | CN1049818C Pharmaceutical use of benzo-thiophenes compound |
| 03/01/2000 | CN1049817C Method for preparation of percutaneously absorbable drug composition |